In the last 15 years, U.S. mortality rates have leveled off or worsened, according to a new report from the National Institutes of Health. One of the lesser-known reasons for this trend is educational level. “Notably, research has found that mortality is [better] among people with a higher level of education,” according to NIH. Let’s dig deeper into this research and what it means for our communities.
What Research Found on Educational Levels
The NIH cites a recent study, published in JAMA Health Forum and led by Boston University School of Public Health. The study examined U.S. mortality rates by educational attainment before, during, and after the COVID-19 pandemic. Along with data from the CDC’s National Center for Health Statistics and the U.S. Census ...
In the United States, cancer is a significant public health challenge. For example, among Latinos, who are 19.5% of the population, rates are higher and prognoses are poorer than other groups. The Latino cancer burden is driven by complex interactions in 13 key areas, according to a new publication from the Task Force: Latino Researchers Against Cancer in the journal Frontiers in Public Health. The task force, led by Dr. Amelie G. Ramirez of UT Health San Antonio and comprised of specialists in oncology, public health, and behavioral sciences, spent a year meeting together to unpack the influences contributing to cancer, from genetics to societal practices. "Findings highlight environmental hazards, genetic susceptibilities, stigmas, and linguistic barriers as significant ...
A recent study from the University of Michigan found that extended family members, such as siblings, cousins and grandparents, are the most influential mentors for Latino emerging adults and can simultaneously empower and constrain young people's efforts to create social change. “It is essential to understand how adults can partner with youth to create social change,” the study states. Let’s dig deeper into this study and what the results mean for families and communities.
The Impact of Extended Family
“Our research reveals that adults play complex, multifaceted roles in these young people’s civic development,” said Wendy de los Reyes, U-M postdoctoral research fellow in the Combined Program in Education and Psychology.” For the study, de los Reyes and her ...
Scientists and collaborators at the Icahn School of Medicine at Mount Sinai recently identified novel genetic interactions that may contribute to congenital heart disease. Congenital heart disease (CHD) is a problem with the heart’s structure at birth. Let’s go beyond the surface and learn more about what the research means and how it can help others!
The Health Impact of Congenital Heart Disease (CHD)
When a disease or condition is congenital, it means someone is born with this condition. Congenital heart diseases or defects occur when “when the heart, or blood vessels near the heart, don’t develop normally before birth. Such defects result when a mishap occurs during heart development soon after conception — often before the mother is aware that she is pregnant,” ...
Cancer continues to be tied with heart disease as the top cause of death for all people, including Latinos. People of different backgrounds suffer higher rates of certain cancer types, are diagnosed at later stages, and are more likely to die from the disease. This is often due to issue with non-medical drivers of health in communities. That’s why researchers choose to keep studying the intersection between background and health issues so that science and medicine can improve cancer outcomes for these individuals and everyone. Here are three cancer studies that focus on cancer and background.
1. Trends in Incidence of Testicular Cancer
Testicular cancer remains the second -most common cancer in men aged 15-39 worldwide, according to a study published in the National ...
Researchers at the Mayo Clinic are working to better understand and find treatment for uveal melanoma, also called melanoma of the eye. Uveal melanoma is a type of cancer that involves one of the three parts of the eye that comprise the uvea: the iris, the ciliary body, and the choroid. The researchers have developed organoid models, or 3D models grown from patient tissue, which accurately reflects a patient’s unique genetic and biological characteristics. “When derived from a patient’s cancer tumor, an organoid will behave and respond to treatments outside the body in a lab (in vitro) just like the original tumor would inside the body (in vivo),” according to a Eureka Alert news release. Let’s look further into this research and how it can impact all ...
Cancer is a big health issue for Latinos and all people. That’s why Dr. Amelie Ramirez, director of Salud America! and the Institute for Health Promotion Research at UT Health San Antonio, partnered with the Mays Cancer Center to create the Advancing the Science of Cancer in Latinos (ASCL) biennial conference. Read the proceedings from the 2018, 2020, and 2022 ASCL Conferences. The 2024 ASCL Conference on Feb. 21-23, 2024, in San Antonio, Texas, welcomed over 280 prominent researchers, physicians, healthcare professionals, patient advocates, and students from across the globe to address cancer health disparities among Latinos. Conference sponsors included: platinum supporters Amgen, AstraZeneca, Bristol Myers Squibb, Genentech, and Gilead; silver supporters GMaP Region 3, ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Demographics and Public Policy: Implications for Latino Cancer
Dr. Elena V. Rios is President & CEO of the National Hispanic Medical Association (NHMA) and president of NHMA’s National Hispanic Health Foundation. Unfairness in the healthcare system Dr. Rios’s presentation began by focusing on the changing demographics in the US. By 2035, Latino individuals will make up 1 out of every 4 Americans, meaning that the future of the country is intertwined in the Latino experience. The current 63 million Latino individuals in the US make up 19% of the population; however, only 9% of oncologists are Latino, and only 1/3 of those are women. This is important in light of the high ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Cancer Center Priorities for Addressing Latino Cancer Health Gaps: A Fire-side Chat with Cancer Center Directors
This special session occurred at 9:00 a.m., Friday, Feb. 23, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. Dr. Yolanda Sanchez is the Maurice and Marguerite Liberman Distinguished Chair in Cancer Research, Professor in the University of New Mexico (UNM) Department of Internal Medicine Division of Molecular Medicine, and UNM Cancer Center Director and Chief Executive Officer. Dr. Sanchez discussed the University of New Mexico Comprehensive Cancer Center (UNMCCC) and its mission to reduce the cancer burden and overcome the tremendous ...
